Physician group names new executive director
Sabrina Mosseau is the new executive director of New York Oncology Hematology P.C. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - January 17, 2019 Category: Pharmaceuticals Authors: Liz Young Source Type: news

Ruth Bader Ginsburg "will retire from the U.S. Supreme Court in January, 2019" says same news source that accurately reported her cancer
(Natural News) Today The Atlantic, a fake news propaganda rag of the lunatic Left, called for the impeachment of Trump. That’s because Leftists have reached “peak panic” mode as rumors are circulating that Ruth Bader Ginsburg is seriously ill and will soon either retire from the court or pass away. The Santa Monica Observer, the... (Source: NaturalNews.com)
Source: NaturalNews.com - January 17, 2019 Category: Consumer Health News Source Type: news

Breast Cancer Patients Do Not Overreact to Genetic Testing
THURSDAY, Jan. 17, 2019 -- Among breast cancer patients, more extensive genetic testing is not associated with increased cancer worry, according to a study recently published in JCO Precision Oncology. Steven J. Katz, M.D., M.P.H., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2019 Category: Pharmaceuticals Source Type: news

Patient recruitment for Phase I Graves ’ disease study
Illingworth Research Group Ltd are coordinating aphase I study to investigate a potential new drug, K1-70, developed to treat patients who have Graves’ disease, thyroid cancer, and patients who would benefit from controlling thyroid stimulating hormone receptor activity.Illingworth Research Group Ltd need a further 8 patients with Graves’ disease to complete this study. For more information, please contact:•        Volunteer Services team at the Medicines Evaluation Unit on 0800 655 6553 and quote study MEU 15/304•...
Source: Society for Endocrinology - January 17, 2019 Category: Endocrinology Source Type: news

Hairdresser saves a father-of-three's life after spotting a lump on his head which was cancer
Adam Shatford, 54, a driving instructor from Northampton, was advised to see a doctor by Erinna Lindfield during a trim. He was diagnosed with stage three melanoma. (Source: the Mail online | Health)
Source: the Mail online | Health - January 17, 2019 Category: Consumer Health News Source Type: news

Prostate cancer warning - how many times do you go to the toilet? Risk revealed
PROSTATE cancer symptoms can be difficult to spot in its early stages, but usually affect the way you pass urine. You could be at risk of the disease ’s signs and symptoms if you use the toilet more often - how many times do you go for a wee every day? (Source: Daily Express - Health)
Source: Daily Express - Health - January 17, 2019 Category: Consumer Health News Source Type: news

Doctors: A ‘ Sentimental Journey ’ in the Cancer Clinic
I am a firm believer in the ability of music to help people express their emotions, hopes and fears, making their medical conditions more tolerable. (Source: NYT Health)
Source: NYT Health - January 17, 2019 Category: Consumer Health News Authors: MIKKAEL A. SEKERES, M.D. Tags: Music Hospice Care Doctors Hospitals Source Type: news

Maggie’s Centres hospital annexes offer refuges of calm
Star architects’ designs allow UK cancer patients, staff and families to feel at ease (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 17, 2019 Category: Pharmaceuticals Source Type: news

Meanwhile: Meet the People Who Seek Out Radon Water (and Then Take a Big Gulp)
The E.P.A. warns that radon causes cancer. But some tourists head to mines in Montana to soak it up. (Source: NYT Health)
Source: NYT Health - January 17, 2019 Category: Consumer Health News Authors: WENDY MACNAUGHTON Tags: Radon Gas Mines and Mining Montana Medicine and Health Source Type: news

Living With Cancer: A Cancer Rap, With Thanks to Nina Simone
After too many cancer-related setbacks and deaths I started belting Nina Simone ’ s protest with new words, invigorated by her spirit of indignant fury. (Source: NYT Health)
Source: NYT Health - January 17, 2019 Category: Consumer Health News Authors: SUSAN GUBAR Tags: Poetry and Poets Music Cancer Simone, Nina Race and Ethnicity Source Type: news

Nanoparticle breakthrough in the fight against cancer
A team of researchers, affiliated with UNIST has recently introduced a novel targeted drug delivery system that can improve the pharmacological and therapeutic properties of conventional cancer treatments. The new technology has dramatically enhanced safety and efficiency through the use of the supramolecularly built protein corona shield as a targeting agent through regulating the interfaces between nanoparticles and biological systems. (Source: World Pharma News)
Source: World Pharma News - January 17, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Cancer Diagnosis May Quadruple Suicide Risk
Title: Cancer Diagnosis May Quadruple Suicide RiskCategory: Health NewsCreated: 1/16/2019 12:00:00 AMLast Editorial Review: 1/17/2019 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 17, 2019 Category: Cancer & Oncology Source Type: news

New PET tracer could aid melanoma detection
A new PET tracer designed to target melanin pigment could improve the detection...Read more on AuntMinnie.comRelated Reading: FDG-PET/CT fails for peripheral T-cell lymphoma outcomes PET/CT makes case for directing cervical cancer treatment FLT-PET points toward survival for glioblastoma patients Extremity PET/CT scans unnecessary for melanoma patients FDG-PET/CT foretells melanoma therapy response (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 17, 2019 Category: Radiology Source Type: news

FDA accepts Roche ’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) for Tecentriq® (atezolizumab) in combination with Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) and carboplatin for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC) who do not have EGFR or ALK genomic tumour aberrations. (Source: Roche Investor Update)
Source: Roche Investor Update - January 17, 2019 Category: Pharmaceuticals Source Type: news

FDA accepts Roche ’s supplemental biologics license application for Tecentriq plus chemotherapy (Abraxane and carboplatin) for the initial treatment of metastatic non-squamous non-small cell lung cancer
Roche today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) for Tecentriq® (atezolizumab) in combination with Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) and carboplatin for the initial (first-line) treatment of people with metastatic non-squamous non-small cell lung cancer (NSCLC) who do not have EGFR or ALK genomic tumour aberrations. (Source: Roche Media News)
Source: Roche Media News - January 17, 2019 Category: Pharmaceuticals Source Type: news

Killer blows? Knockout study of pair of mouse MicroRNA provides cancer insight
(Tokyo Medical and Dental University) Tokyo Medical and Dental University (TMDU) researchers used knockout mouse models created by gene editing to reveal that the miRNA miR-146b, like miR-146a, is involved in the development of cancers, with them having similar but not identical effects. The knockout mice showed high rates of B-cell lymphoma and acute myeloid leukemia, which was associated with the absence of miRNA causing NF-κB overactivation. These insights should help in the fight against cancers involving miRNA dysregulation. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 17, 2019 Category: Biology Source Type: news

Using Radiation Therapy to Reduce Recurrence in DCIS
Cancer Network spoke with Dr. Carmen Bergom about advancements in the treatment of DCIS and the importance of using local recurrence patterns to help guide future research. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Carmen Bergom, MD, PhD Source Type: news

Researchers race against extinction to uncover tree's cancer-fighting properties
(Purdue University) As the population of a fir tree in China dwindles, researchers are racing to replicate its cancer-fighting molecules. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 17, 2019 Category: Biology Source Type: news

Advanced squamous cell carcinoma of the head and neck: Pembrolizumab prolongs survival
(Institute for Quality and Efficiency in Health Care) quamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumours of the head and neck, i.e. in the mouth, the pharynx or the larynx: If recurrences or metastases occur during or after platinum-based chemotherapy, the disease is generally considered incurable. The goal is then to prolong the remaining lifetime while maintaining the best possible quality of life. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

NCI awards $1.7 million to UIC for research on Southeast Asian fruit
(University of Illinois at Chicago) A new $1.7 million grant from the National Cancer Institute will enable researchers at the University of Illinois at Chicago to study the fruit and its potential as a treatment for prostate cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

New combination blood test for pancreatic cancer may catch disease earlier
(Van Andel Research Institute) A new approach to pancreatic cancer screening may help doctors detect the disease in people at high risk before it reaches more advanced and difficult-to treat stages.A team led by Van Andel Research Institute (VARI) scientists has developed a new, simple blood test that, when combined with an existing test, detects nearly 70 percent of pancreatic cancers with a less than 5 percent false-positive rate. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

The Emerging Profile of Immunotherapy Approaches in the Treatment of AML
Dr. Daver discusses immunotherapy approaches for patients with acute myeloid leukemia (AML), and his recent study results on the combination of azacitidine and nivolumab. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Naval Daver, MD Source Type: news

Pathologic Hip Fracture in a 49-Year-Old Man With Widespread Metastatic Sclerotic Bone Lesions
In this case, we examine a 49-year-old man with widespread metastatic sclerotic bone lesions. What is your diagnosis? (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Mehmet Sitki Copur, MD, Adam Horn, MD, Pornchai Jonglertham, MD Source Type: news

Researchers ID Common Terminology to Describe Non-Melanoma Skin Cancers
The findings of a systematic review may help standardize reflectance confocal microscopy terminology, which is used to describe non-melanocytic lesions. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Oncology Conference Highlights, Q4
Our team reviews 2018 conference highlights in oncology care, including studies from ASH, SABCS, and SIO. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Jennifer Leavitt, MS, Traci DeVito, Naveed Saleh, MD, MS Source Type: news

Key Advances in Oncology, 2018
Our team reviews the most important advances in oncology in 2018, including those in breast cancer, hematologic cancers, lung cancer, immunotherapy, and more. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Traci DeVito, Jennifer Leavitt, MS, Naveed Saleh, MD, MS Source Type: news

Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer
In this review, we discuss known data and the differences between the different immune checkpoint inhibitors, as well as future avenues to explore with immuno-oncologic agents in urothelial cancer. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Omar Alhalabi, MD, Amishi Y. Shah, MD, Emily A. Lemke, DNP, AGPCNP-BC, AOCNP, Jianjun Gao, MD, PhD Source Type: news

Current Strategies for the Management of Locoregional Breast Cancer Recurrence
In this review, we focus primarily on describing locoregional and systemic management strategies for isolated locoregional recurrences manifesting as isolated first-failure events following mastectomy or breast-conserving therapy. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Irene L. Wapnir, MD, Atif Khan, MD, MS Source Type: news

Management of Neutropenic Toxicity From CDK4/6 Inhibitors
Kristina Frinzi Byers, PharmD, BCOP, discusses how to manage neutropenic toxicity from treatment with CDK4/6 inhibitors for HR-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Kristina Frinzi Byers, PharmD, BCOP Source Type: news

Vitamin D and Omega-3 Supplements for Preventing Cancer and Other Chronic Diseases
Dr. Manson discusses the results of the recently published VITAL study that tested whether vitamin D or omega-3 supplements could be effective for primary prevention of cancer and cardiovascular disease. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: JoAnn Manson, MD, DrPH Source Type: news

Immunotherapy Approaches in AML
Cancer Network sat down with Dr. Naval Daver to discuss advancements and discoveries in immunotherapy for AML patients. (Source: CancerNetwork)
Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Naval Daver, MD Source Type: news

Scientists learn how common virus reactivates after transplantation
(Fred Hutchinson Cancer Research Center) A new study in Science challenges long-held theories of why a common virus -- cytomegalovirus, or CMV -- can reactivate and become a life-threatening infection in people with a compromised immune system, including blood cancer patients undergoing bone marrow transplantation. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Many hepatitis infections go undiagnosed in cancer patients
(SWOG) Results from the largest study of hepatitis B and C and HIV infection prevalence in cancer patients show an alarmingly high rate of undiagnosed acute and chronic hepatitis B and C. Hepatitis B and C are serious but treatable viral infections that cancer patients should know they have - because these viruses can cause life-threatening complications when certain cancer treatments are used. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Russian scientists creating new tools for diagnosing cancer
(Ural Federal University) A group of scientists from Russia's Ural Federal University, headed by Professor Grigory Zyryanov, synthesized a group of multi-purpose fluorophores. The scientists told about the content and results of their research on the unique technology in a respected international scientific journal " Dyes and Pigments " . (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Right on target: Light hybrid molecule stop tumor growth in mice
(National University of Science and Technology MISIS) A team of scientists from the National University of Science and Technology 'MISIS', the Moscow Technological University (MIREA) and the Pirogov Russian National Research Medical University has experimentally proved the effectiveness of the formerly suggested 'light' method in oncotherapy. In a series of laboratory preclinical tests, the tumor growth stopped in 70 percent of mice, treated according to the innovative scheme. The results are presented in Pharmaceutics journal. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Population study finds striking disparities in health behaviors and screening in Indiana
(Regenstrief Institute) A population health study from IUPUI and Regenstrief Institute has identified striking socioeconomic and racial disparities in health behavior and in the receipt of cancer screening in the 34 Indiana counties with cancer death rates higher than the state's average. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Millions of Americans exposed to elevated nitrate levels in drinking water
(Silent Spring Institute) More than 5.6 million Americans are exposed to nitrate in drinking water at levels that could cause health problems. In this first analysis of its kind, researchers also found that water systems with higher nitrate levels tend to serve communities with higher proportions of Hispanic residents. The findings could help inform programs to assist community water systems that might be vulnerable to contamination. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

New study identifies specific obesity-related risk factors for kidney cancer
(Spectrum Health) A new study confirms the long-suspected role of obesity as a risk factor for developing renal cell carcinoma (RCC), a type of kidney cancer, and identifies several specific obesity-related factors. These factors include multiple measures of obesity, diastolic blood pressure and fasting insulin. In contrast, the study found little evidence for an association with RCC risk for systolic blood pressure, circulating lipids, diabetes or fasting glucose. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

UCLA scientists create a renewable source of cancer-fighting T cells
(University of California - Los Angeles Health Sciences) A study by UCLA researchers is the first to demonstrate a technique for coaxing pluripotent stem cells -- which can give rise to every cell type in the body and which can be grown indefinitely in the lab -- into becoming mature T cells capable of killing tumor cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Resist! TAK1 enables endothelial cells to avoid apoptosis
(Osaka University) TNFα-induced cell death is tightly regulated and resisted in endothelial cells. Here, an Osaka University-led research team used a unique type of mouse, in which TAK1 could be deleted in specific tissues, to show that TAK1 is an essential component in ensuring survival of endothelial cells during inflammation and injury, and that TAK1 could be a novel target for anti-angiogenic therapy in cancer treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

Nanoparticle breakthrough in the fight against cancer
(Ulsan National Institute of Science and Technology(UNIST)) A recent study, affiliated with South Korea's Ulsan National Institute of Science and Technology (UNIST) has introduced a novel targeted drug delivery system in the fight against cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

Addressing expected challenges after resumption of HPV vaccination
(Osaka University) Researchers at Osaka University present measures for reducing a risk of uterine cervical cancer that increased by the suspension of the Japanese government recommendation for the Human Papillomavirus (HPV) vaccination and for promoting HPV vaccination after its resumption (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 17, 2019 Category: International Medicine & Public Health Source Type: news

Rutgers scientist identifies gene responsible for spread of prostate cancer
(Rutgers University) A recent study has found that a specific gene in cancerous prostate tumors indicates when patients are at high-risk for the cancer to spread, suggesting that targeting this gene can help patients live longer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

World Trade Center responders at increased risk for head and neck cancers
(Rutgers University) A Rutgers study has found a significant increase in head and neck cancers among workers and volunteers who responded to the 9/11 terrorist attacks on the World Trade Center (WTC), pointing to newly emerging risks that require ongoing monitoring and treatment of those who were exposed during the initial response. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 17, 2019 Category: Cancer & Oncology Source Type: news

Fashion model poses with her ostomy bags to inspire other cancer survivors
Jearlean Taylor has learned to embrace her ostomy bags — and now wants to inspire others to do the same (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 17, 2019 Category: Consumer Health News Source Type: news

Young dad thanks blood donors who saved his life
As Tyler Bacon gripped the lectern in Carnesale Commons and scanned the crowd gazing at him expectantly, he struggled to hold back tears.The 39-year-old father of two from Thousand Oaks was finally meeting some of the more than two dozen people whose blood and platelet donations sustained his life during cancer treatment at  Ronald Reagan UCLA Medical Center.  “Because you showed up and donated, my parents still have a son,” Bacon said. “My children have a dad. My wife has a husband.”His voice quaking with emotion, he added, “All the gratitude in the world would not be enough to say ...
Source: UCLA Newsroom: Health Sciences - January 17, 2019 Category: Universities & Medical Training Source Type: news

This fashion model poses with her ostomy bags to inspire other cancer survivors
Jearlean Taylor learned to embrace her ostomy bags — and now wants to inspire others to do the same (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - January 17, 2019 Category: Consumer Health News Source Type: news

Teenage cancer survival 'on the up' in England, report finds
But youngsters living in poorer areas of England had lower chances of survival, cancer data found. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - January 17, 2019 Category: Consumer Health News Source Type: news

Response to Immune Checkpoint Tx Low in Relapsed/Refractory DLBCL
(MedPage Today) -- Such patients likely to fare better on CAR T-cell immunotherapy than on nivolumab, researchers say (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - January 17, 2019 Category: Hematology Source Type: news

Scientists have learned how to interrupt cancer cell growth; allowing them to prevent cancer’s adaptation to treatment
(Natural News) It has been 16 years since the human genome was decoded — an accomplishment that scientists hoped would someday prove useful in cancer therapy. There was an optimistic, if not naive, belief that we could simply “switch off” cancer-causing genes. Nevertheless, oncologists are still encountering problems with this concept more than a decade... (Source: NaturalNews.com)
Source: NaturalNews.com - January 17, 2019 Category: Consumer Health News Source Type: news